Pakistanis angry over detentions in Times Sq. case Monday, May 24, 2010
ISLAMABAD – Relatives of three men detained by Pakistan for alleged links to the suspect in the attempted Times Square bombing say the men are innocent.
They
AFP - Thursday, August 6TAIPEI (AFP) - - Taiwan's Beijing-friendly government on Wednesday denied boycotting an Australian film festival amid a row over the e
BERLIN (Reuters) - Chancellor Angela Merkel suffered a double blow on Thursday as a senior party ally in east German
Minister seeks closure of anti-Berlusconi websites Wednesday, December 16, 2009
ROME (AFP) - – The Italian government moved Tuesday to close down Internet sites encouraging further violence against Prime Minister Silvio Berlusconi, who
By ELAINE KURTENBACH,AP Business Writer AP - Wednesday, March 18SHANGHAI - Asia's stock market rally seemed to be running out of steam Wednesday, despite an
Edition:
U.S.
Africa
Arabic
Argentina
Brazil
Canada
China
France
Germany
India
Italy
Japan
Latin America
Mexico
Russia
Spain
United Kingdom
Home
Business
Business Home
Economy
Technology
Media
Small Business
Legal
Deals
Earnings
Social Pulse
Business Video
The Freeland File
Aerospace & Defense
Markets
Markets Home
U.S. Markets
European Markets
Asian Markets
Global Market Data
Indices
M&A
Stocks
Bonds
Currencies
Commodities
Futures
Funds
peHUB
World
World Home
U.S.
Brazil
China
Euro Zone
Japan
Mexico
Russia
India Insight
World Video
Reuters Investigates
Decoder
Politics
Politics Home
Election 2012
Campaign Polling
Tales from the Trail
Political Punchlines
Supreme Court
Politics Video
Tech
Technology Home
MediaFile
Science
Tech Video
Tech Tonic
Social Pulse
Opinion
Opinion Home
Chrystia Freeland
John Lloyd
Felix Salmon
Jack Shafer
David Rohde
Bernd Debusmann
Nader Mousavizadeh
Lucy P. Marcus
David Cay Johnston
Bethany McLean
Anatole Kaletsky
Edward Hadas
Hugo Dixon
Ian Bremmer
Lawrence Summers
Susan Glasser
The Great Debate
Steven Brill
Jack & Suzy Welch
Frederick Kempe
Christopher Papagianis
Mark Leonard
Breakingviews
Equities
Credit
Private Equity
M&A
Macro & Markets
Politics
Breakingviews Video
Money
Money Home
Tax Break
Lipper Awards 2012
Global Investing
MuniLand
Unstructured Finance
Linda Stern
Mark Miller
John Wasik
James Saft
Analyst Research
Alerts
Watchlist
Portfolio
Stock Screener
Fund Screener
Personal Finance Video
Money Clip
Investing 201
Life
Health
Sports
Olympics
Arts
Faithworld
Business Traveler
Entertainment
Oddly Enough
Lifestyle Video
Pictures
Pictures Home
Reuters Photographers
Full Focus
Video
Reuters TV
Reuters News
Article
Comments (0)
Full Focus
Editor's choice
A selection of our best photos from the past 24 hours. See more
Images of June
Follow Reuters
Facebook
Twitter
RSS
YouTube
Read
North Korean leader cements control over army
17 Jul 2012
Murder suspect kills self after stealing plane in Utah
17 Jul 2012
Facebook shares slide as user growth in question
17 Jul 2012
Suspect charged in Alabama bar shooting that wounded 17
|
17 Jul 2012
Bernanke offers gloomy view but few new hints on easing
17 Jul 2012
Discussed
119
Obama allies tell Romney to ”quit whining” about Bain attacks
97
Syria hit by diplomatic defection as U.N. battles divisions
86
World outrage at Syria ”massacre”, but no action
Watched
Taking to the streets against budget cuts in Spain
Tue, Jul 17 2012
Girl caught after falling from third-story window
Tue, Jul 17 2012
Mars landing not a crazy concept but risky: program director
Mon, Jul 16 2012
Pictures
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Free Syrian Army
A rare look inside the Syrian rebel army fighting to overthrow Assad. Slideshow
Smithsonian: Shapes and shadows
Artistic images of the Smithsonian Institution, the world's largest museum and research complex. Slideshow
Australian woman wins multi-million Thalidomide payout from Diageo
Tweet
Share this
Email
Print
Analysis & Opinion
3rd Circuit shocker: Pay-for-delay drug settlements are illegal
Porn copyright troll targets strike back in new class action
Related Topics
World »
Health »
Australia »
MELBOURNE |
Wed Jul 18, 2012 2:36am EDT
MELBOURNE (Reuters) - An Australian woman has won a multi-million dollar payout from UK company Diageo Plc, the local distributor of the drug Thalidomide that caused birth defects in thousand of babies around the world in the 1960s, her lawyers said on Wednesday.
Lynette Rowe, 50, was born without arms and legs after her mother Wendy took Thalidomide for a month while pregnant. At the time the drug was prescribed as a treatment for morning sickness.
The settlement with Rowe could pave the way for more than 100 other Thalidomide victims in Australia and New Zealand to receive compensation through a class action, the law firm Slater & Gordon said.
The drug was made by German company Grunenthal and was licensed in Australia to the firm Distillers, which was later taken over by Diageo. Grunenthal did not contribute to the settlement, the law firm said.
"Those pills that Wendy and thousands of women took 50 years ago have caused so much heartache and suffering, but at least something positive is now being done to put some things right," Lynette's father Ian said in a statement released by Slater & Gordon.
Rowe's settlement follows a A$50 million ($51 million)payment Diageo agreed to make in 2010 to 45 Thalidomide victims in Australia and New Zealand, who sought help to cope with the mounting costs of care as they were living longer than expected.
"The approach announced today is both fair and equitable to all involved in this very sensitive and difficult situation," said Diageo director Ian Wright.
Diageo had "agreed a process that will explore resolution of as many of the remaining group claims as possible," he said.
The cases have been closely watched in the United States, where a complaint has been filed against GlaxoSmithKline, Sanofi-Aventis, Avantor Performance Materials and Grunenthal, with several plaintiffs claiming their birth defects resulted from their mothers' use of Thalidomide.
The drug was widely used by pregnant women in Europe in the late 1950s and early 1960s to treat nausea, until evidence emerged that it caused terrible birth deformities.
That led to some countries, including Britain and Germany, setting up compensation systems for victims, but there was no such system in the United States, where the drug was never approved by the Food and Drug Administration but was used in clinical trials. ($1 = 0.9757 Australian dollars)
(Reporting by Aicha Marhfour; Editing by Daniel Magnowski)
World
Health
Australia
Related Quotes and News
Company
Price
Related News
Tweet this
Link this
Share this
Digg this
Email
Reprints
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (0)
Be the first to comment on reuters.com.
Add yours using the box above.
Edition:
U.S.
Africa
Arabic
Argentina
Brazil
Canada
China
France
Germany
India
Italy
Japan
Latin America
Mexico
Russia
Spain
United Kingdom
Back to top
Reuters.com
Business
Markets
World
Politics
Technology
Opinion
Money
Pictures
Videos
Site Index
Legal
Bankruptcy Law
California Legal
New York Legal
Securities Law
Support & Contact
Support
Corrections
Connect with Reuters
Twitter
Facebook
LinkedIn
RSS
Podcast
Newsletters
Mobile
About
Privacy Policy
Terms of Use
AdChoices
Copyright
Our Flagship financial information platform incorporating Reuters Insider
An ultra-low latency infrastructure for electronic trading and data distribution
A connected approach to governance, risk and compliance
Our next generation legal research platform
Our global tax workstation
Thomsonreuters.com
About Thomson Reuters
Investor Relations
Careers
Contact Us
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.